Пятница, 29.03.2024, 11:43
The Vinnica Post
Главная Регистрация Вход
Приветствую Вас, Гость · RSS
Меню сайта
Реклама
Каталог товаров

https://vilingstore.net
Другие города

Добавить объявления 

В других городах Украины

Добавить в АР Крым

Добавить в Киев

Добавить в Харьков

Добавить в Одессу

Добавить в Днепропетровск

Добавить в Донецк

Добавить в Запорожье

Добавить во Львов

Добавить в Кривой Рог

Добавить в Николаев

Добавить в Мариуполь

Добавить в Луганск

Добавить в Севастополь

Добавить в Винница

Добавить в Макеевка

Добавить в Симферополь

Добавить в Херсон

Добавить в Полтава

Добавить в Чернигов

Добавить в Черкассы

Добавить в Житомир

Добавить в Сумы

Добавить в Хмельницкий

Добавить в Горловка

Статистика

Онлайн всего: 1
Гостей: 1
Пользователей: 0
Форма входа
 Доска объявлений Винница
Главная » Доска объявлений » Услуги в разных сферах Винница » Страхование [ Добавить объявление ]

Dr. Misha V. Blagosklonny
Предложение | 15.10.2019, 18:07

Misha V. Blagosklonny graduated with an MD and PhD from First Pavlov State Medical
University of St. Petersburg, Russia. Dr. Mikhail V. Blagosklonny has then
Relocated to the United States, where he was
Awarded the prestigious Fogarty Fellowship from the National Institutes of Health.
During his fellowship in Leonard Neckers’ laboratory at the National
Cancer Institute (NCI), he was a co-author of 18 publications on
Various biomedical themes, including targeting
HSP90, p53, Bcl2, Erb2, and Raf-1. He also was the last author on a clinical phase I/II
Trial article.
 
After authoring seven papers during a brief yet productive
Senior research fellowship in the El-Deiry Cancer Research Lab at the University of Pennsylvania,
Dr. Blagosklonny returned to NCI to work with Tito Fojo. Together, they
Published 26 papers. In addition, Dr. Mikhail Blagosklonny published anumber of experimental research articles and theoretical papers as sole
Author. Those sole-author publications
Encompassed two important topics.
The first of these mentioned selectively killing cancer
Cells with deregulated cell cycle or drug resistance via
Exploiting their resistance. The results and underlying
Notion were so revolutionary that they were inadequately cited by
Other scientists as “reversal of resistance, ” even though the work was
Named, “Exploiting of drug resistance instead of its reversal. ” One major
Supporter of this concept was the world-famous scientist Arthur Pardee, with whom Dr.
Blagosklonny co-authored a joint article in 2001.
 
The second theme throughout Dr. Blagosklonny’s sole-author publications
Is a research method to develop knowledge via
Bringing several facts together from seemingly irrelevant fields.
This results in new concepts with testable predictions, which in
Turn can be “tested” by analyzing the literature further. Once again, the
Concept was co-authored by Arthur Pardee in a 2002 publication in Nature. The
First success of the new research method was the description of the feedback
Regulation of p53, as confirmed by the discovery of mdm2/p53 loop; and the
Explanation why mutant p53 is always overexpressed, published in 1997. The most
Important result discovered by Dr.
Blagosklonny’s research methods is the hyperfunction (or quasi-programmed)
Theory of aging and the revelation of rapamycin as an exclusively well-tolerated
Anti-aging drug, published in 2006. As mentioned in Scientific American,
Michael Hall, who discovered mTOR in 1991, gives Dr. Blagosklonny credit for
“connecting dots that others don' t even see. ”
 
In 2002, Dr. Blagosklonny became associate professor of medicine at New York Medical College.
He decided to assume responsibilities as a senior scientist at Ordway
Research Institute in Albany, New York, in 2005, prior to accepting another
Position at Roswell Park Cancer Institute as professor of oncology in 2009.
 
Since coming to Roswell Park Comprehensive Cancer Center in 2009, Dr. Blagosklonny
Has studied the prevention of cancer (an age-related disease) by
Preventing organism aging — in other words, “preventing cancer
By remainng young. ” His lab closely collaborated with
Andrei Gudkov’s and completed research on the suppression of
Cellular senescence, namely suppression of cellular conversion from healthy quiescence to
Permanent senescence. This resulted in the discovery of additional anti-aging
Medications beyond rapamycin. The cell culture studies were
Complemented by studies in mice, including a few models such as
Standard and aging mice, p53-deficient mice, and mice on a high-fat diet.
 
Dr. Mikhail Blagosklonny has also published extensively on the stoppage of cellular
Senescence by rapamycin as well as other mTOR inhibitors, life
Extension and cancer prevention in mice, and combinations of anti-
Aging drugs to be used in humans. A
Rapamycin-based combination of seven clinically available medications has
Been named the “Koschei Formula” and is now utilized for the treatment of aging in patients
At the Alan Green Clinic in Little Neck, New York.

 

Добавил: greenvikzal |
Просмотров: 222 | Рейтинг: 0.0/0
Всего комментариев: 0
Добавлять комментарии могут только зарегистрированные пользователи.
[ Регистрация | Вход ]
Copyright MyCorp © 2024
Поиск
Друзья сайта
  • Объявления Днепропетровск
  • Объявления Одесса
  • Объявления Харьков
  • Объявления Донецк
  • Объявления Киев
  • Объявления Кривой рог
  • Объявления Запорожье
  • Объявления Мариуполь
  • Объявления Николаев
  • Объявления Львов
  • Объявления Крым
  • Сделать бесплатный сайт с uCoz